Aquestive Therapeutics (AQST) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Aquestive Therapeutics (AQST) reported $13.54 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 4.2$0.13 for the same period compares to -$0.03 a year ago.The reported revenue compares to the Zacks Consensus Estimate of$12.69 million, representing a surprise of +6.68%. The company delivered an EPS surprise of -8.33%, with the consensus EPS estimate being -$0.12.While investors closely watch year-over-year changes in headline numbers -- revenue and ...